News
REGN ▲ +2.2% - Regeneron Pharmaceuticals, Inc.
REGN ▲ +2.2% - Regeneron Pharmaceuticals, Inc.
$REGN - Pasatru™ (garetosmab-grts) Demonstrates Zero New Heterotopic Ossification (HO) Lesions in Adult Fibrodysplasia Ossificans Progressiva (FOP) Patients During OPTIMA Trial Extension
12-OCT-2026 12:06 PM ET
Share this post
More filings for $REGN
REGN ▼ -0.1% - Regeneron Pharmaceuticals, Inc.Oct 6, 2026REGN ▼ -3.3% - Regeneron Pharmaceuticals, Inc.Oct 1, 2026REGN ▼ -3.2% - Regeneron Pharmaceuticals, Inc.Oct 1, 2026REGN ▲ +1.1% - Regeneron Pharmaceuticals, Inc.Oct 1, 2026REGN ▼ -0.7% - Regeneron Pharmaceuticals, Inc.Sep 24, 2026
View full $REGN filing history →💬 Comments
Loading comments…
Leave a comment